Beyond BRCA1 and BRCA2 wild-type breast and/or ovarian cancer families: Germline mutations in TP53 and PTEN

1. Blanco, A.
2. Graña, B.
3. Fachal, L.
4. Santamariña, M.
5. Cameselle-Teijeiro, J.
6. Ruíz-Ponte, C.
7. Carracedo, Á.
8. Vega, A.